Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 26-Aug-24 5:37 PM View:  | Torrente Josephine Director | Agile Therapeutics, Inc. (AGRX) | 26-Aug-24 | Disposition | 987 | $1.52 | $1,500.24 | (100%) 0.99K to 0 | |
| 26-Aug-24 5:32 PM View: | Fischer Seth H.Z. Director | Agile Therapeutics, Inc. (AGRX) | 26-Aug-24 | Disposition | 976 | $1.52 | $1,483.52 | (100%) 0.98K to 0 | |
| 26-Aug-24 5:39 PM View: | Welsh Amy Chief Commercial Officer | Agile Therapeutics, Inc. (AGRX) | 26-Aug-24 | Disposition | 13,500 | $1.52 | $20,520.00 | (100%) 13.5K to 0 | |
| 26-Aug-24 5:33 PM View: | Altomari Alfred Chief Executive Officer | Agile Therapeutics, Inc. (AGRX) | 26-Aug-24 | Disposition | 47,749 | $1.52 | $72,578.50 | (100%) 47.75K to 0 | |
| 26-Aug-24 5:30 PM View: | Hubbard John W Director | Agile Therapeutics, Inc. (AGRX) | 26-Aug-24 | Disposition | 976 | $1.52 | $1,483.52 | (100%) 0.98K to 0 | |
| 26-Aug-24 5:34 PM View: | Carson Sandra Director | Agile Therapeutics, Inc. (AGRX) | 26-Aug-24 | Disposition | 973 | $1.52 | $1,478.96 | (100%) 0.97K to 0 | |
| 26-Aug-24 5:45 PM View: | Gilmore Geoffrey Chief Administrative Officer | Agile Therapeutics, Inc. (AGRX) | 26-Aug-24 | Disposition | 20,256 | $1.52 | $30,789.10 | (100%) 20.26K to 0 | |
| 26-Aug-24 5:35 PM View: | Barbari Sharon Surrey Director | Agile Therapeutics, Inc. (AGRX) | 26-Aug-24 | Disposition | 973 | $1.52 | $1,478.96 | (100%) 0.97K to 0 | |
| 26-Aug-24 5:42 PM View: | Coiante Scott M Chief Financial Officer | Agile Therapeutics, Inc. (AGRX) | 26-Aug-24 | Disposition | 20,080 | $1.52 | $30,521.60 | (100%) 20.08K to 0 | |
| 26-Aug-24 5:41 PM View: | Conway Robert G Chief Supply Chain Officer | Agile Therapeutics, Inc. (AGRX) | 26-Aug-24 | Disposition | 13,529 | $1.52 | $20,564.10 | (100%) 13.53K to 0 | |
| 26-Aug-24 5:40 PM View: | Korner Paul Chief Medical Officer | Agile Therapeutics, Inc. (AGRX) | 26-Aug-24 | Disposition | 13,500 | $1.52 | $20,520.00 | (100%) 13.5K to 0 | |
| 04-Oct-23 4:45 PM View: | Coiante Scott M Chief Financial Officer | Agile Therapeutics, Inc. (AGRX) | 03-Oct-23 | Grant | 20,000 | -- | -- | 25000% 80 to 20.08K | |
| 30-Jun-23 4:36 PM View: | Gilmore Geoffrey Chief Administrative Officer | Agile Therapeutics, Inc. (AGRX) | 28-Jun-23 | Grant | 20,216 | -- | -- | 50540% 40 to 20.26K | |
| 30-Jun-23 4:37 PM View: | Altomari Alfred Chief Executive Officer Director | Agile Therapeutics, Inc. (AGRX) | 28-Jun-23 | Grant | 46,463 | -- | -- | 3613% 1.29K to 47.75K | |
| 30-Jun-23 4:37 PM View: | Conway Robert G Chief Supply Chain Officer | Agile Therapeutics, Inc. (AGRX) | 28-Jun-23 | Grant | 13,500 | -- | -- | 46552% 29 to 13.53K | |
| 30-Jun-23 4:38 PM View: | Korner Paul Chief Medical Officer | Agile Therapeutics, Inc. (AGRX) | 28-Jun-23 | Grant | 13,500 | -- | -- | 100% 0 to 13.5K | |
| 30-Jun-23 4:38 PM View: | Welsh Amy Chief Commercial Officer | Agile Therapeutics, Inc. (AGRX) | 28-Jun-23 | Grant | 13,500 | -- | -- | 100% 0 to 13.5K | |
| 09-Jun-23 5:08 PM View: | Barbari Sharon Surrey Director | Agile Therapeutics, Inc. (AGRX) | 08-Jun-23 | Grant | 935 | -- | -- | 2397% 39 to 0.97K | |
| 09-Jun-23 5:13 PM View: | Torrente Josephine Director | Agile Therapeutics, Inc. (AGRX) | 08-Jun-23 | Grant | 935 | -- | -- | 1764% 53 to 0.99K | |
| 09-Jun-23 5:12 PM View: | Fischer Seth H.Z. Director | Agile Therapeutics, Inc. (AGRX) | 08-Jun-23 | Grant | 935 | -- | -- | 2280% 41 to 0.98K | |
| 09-Jun-23 5:10 PM View: | Hubbard John W Director | Agile Therapeutics, Inc. (AGRX) | 08-Jun-23 | Grant | 935 | -- | -- | 2280% 41 to 0.98K | |
| 09-Jun-23 5:09 PM View: | Carson Sandra Director | Agile Therapeutics, Inc. (AGRX) | 08-Jun-23 | Grant | 935 | -- | -- | 2397% 39 to 0.97K | |
| 29-Aug-22 8:30 AM View: | Altomari Alfred Chief Executive Officer Director | Agile Therapeutics, Inc. (AGRX) | 26-Aug-22 | Market Purchase | 50,000 | $0.45 | $22,500.00 | 349% 14.34K to 64.34K | (11%) |
| 10-Jun-22 4:47 PM View: | Fischer Seth H.Z. Director | Agile Therapeutics, Inc. (AGRX) | 09-Jun-22 | Grant | 670 | -- | -- | 48% 1.4K to 2.07K | |
| 10-Jun-22 4:47 PM View: | Hubbard John W Director | Agile Therapeutics, Inc. (AGRX) | 09-Jun-22 | Grant | 670 | -- | -- | 48% 1.4K to 2.07K | |
| 10-Jun-22 4:45 PM View: | Torrente Josephine Director | Agile Therapeutics, Inc. (AGRX) | 09-Jun-22 | Grant | 670 | -- | -- | 34% 1.99K to 2.66K | |
| 10-Jun-22 4:46 PM View: | Shetty Ajit Director | Agile Therapeutics, Inc. (AGRX) | 09-Jun-22 | Grant | 670 | -- | -- | 43% 1.57K to 2.24K | |
| 10-Jun-22 4:48 PM View: | Carson Sandra Director | Agile Therapeutics, Inc. (AGRX) | 09-Jun-22 | Grant | 670 | -- | -- | 52% 1.28K to 1.95K | |
| 10-Jun-22 4:45 PM View: | Tursi James Patrick Director | Agile Therapeutics, Inc. (AGRX) | 09-Jun-22 | Grant | 670 | -- | -- | 48% 1.4K to 2.07K | |
| 10-Jun-22 4:49 PM View: | Barbari Sharon Surrey Director | Agile Therapeutics, Inc. (AGRX) | 09-Jun-22 | Grant | 670 | -- | -- | 52% 1.28K to 1.95K | |
| 14-Oct-21 8:01 AM View: | Reilly Dennis Chief Financial Officer | Agile Therapeutics, Inc. (AGRX) | 13-Oct-21 | Purchase | 58,824 | -- | -- | 23% 251.31K to 310.13K | |
| 14-Oct-21 8:00 AM View: | Altomari Alfred Chief Executive Officer Director | Agile Therapeutics, Inc. (AGRX) | 13-Oct-21 | Purchase | 58,824 | -- | -- | 11% 514.91K to 573.73K | |
| 15-Oct-21 4:05 PM View: | Perceptive Advisors LLC 10% Owner | Agile Therapeutics, Inc. (AGRX) | 13-Oct-21 | Market Purchase | 5,734,560 | $0.85 | $4,874,380.00 | 36% 15.92M to 21.65M | (10%) |
| 08-Oct-21 5:03 PM View: | Torrente Josephine Director | Agile Therapeutics, Inc. (AGRX) | 07-Oct-21 | Grant | 79,593 | -- | -- | 100% 0 to 79.59K | |
| 29-Jul-21 7:52 PM View: | Altomari Alfred Chief Executive Officer Director | Agile Therapeutics, Inc. (AGRX) | 29-Jul-21 | Market Purchase | 26,200 | $1.26 | $33,095.80 | 5% 488.71K to 514.91K | (41%) |
| 28-Jul-21 8:57 PM View: | Reilly Dennis Chief Financial Officer | Agile Therapeutics, Inc. (AGRX) | 27-Jul-21 | Market Purchase | 50,000 | $1.08 | $54,145.00 | 25% 201.31K to 251.31K | (31%) |
| 10-Jun-21 7:10 PM View: | Shetty Ajit Director | Agile Therapeutics, Inc. (AGRX) | 08-Jun-21 | Grant | 24,510 | -- | -- | 64% 38.34K to 62.85K | |
| 11-Jun-21 5:55 PM View: | Carson Sandra Director | Agile Therapeutics, Inc. (AGRX) | 08-Jun-21 | Grant | 24,510 | -- | -- | 92% 26.79K to 51.3K | |
| 10-Jun-21 7:08 PM View: | Tursi James Patrick Director | Agile Therapeutics, Inc. (AGRX) | 08-Jun-21 | Grant | 24,510 | -- | -- | 78% 31.34K to 55.85K | |
| 10-Jun-21 7:11 PM View: | Barbari Sharon Surrey Director | Agile Therapeutics, Inc. (AGRX) | 08-Jun-21 | Grant | 24,510 | -- | -- | 92% 26.79K to 51.3K | |
| 10-Jun-21 7:13 PM View: | Fischer Seth H.Z. Director | Agile Therapeutics, Inc. (AGRX) | 08-Jun-21 | Grant | 24,510 | -- | -- | 78% 31.34K to 55.85K | |
| 10-Jun-21 7:12 PM View: | Hubbard John W Director | Agile Therapeutics, Inc. (AGRX) | 08-Jun-21 | Grant | 24,510 | -- | -- | 78% 31.34K to 55.85K | |
| 19-May-21 8:30 AM View: | Altomari Alfred Chief Executive Officer Director | Agile Therapeutics, Inc. (AGRX) | 18-May-21 | Market Purchase | 20,000 | $1.61 | $32,200.00 | 4% 468.71K to 488.71K | (54%) |
| 12-May-21 4:31 PM View: | Reilly Dennis Chief Financial Officer | Agile Therapeutics, Inc. (AGRX) | 11-May-21 | Market Purchase | 20,000 | $1.35 | $27,000.00 | 11% 181.31K to 201.31K | (45%) |
| 30-Mar-21 4:48 PM View: | Butch Jason Principal Accounting Officer | Agile Therapeutics, Inc. (AGRX) | 29-Mar-21 | Market Purchase | 1,358 | $1.99 | $2,702.42 | 7% 18.64K to 20.0K | (62%) |
| 30-Mar-21 4:48 PM View: | Butch Jason Principal Accounting Officer | Agile Therapeutics, Inc. (AGRX) | 26-Mar-21 | Market Purchase | 8,642 | $2.01 | $17,370.40 | 86% 10.0K to 18.64K | (63%) |
| 23-Mar-21 5:23 PM View: | Reilly Dennis Chief Financial Officer | Agile Therapeutics, Inc. (AGRX) | 23-Mar-21 | Market Purchase | 50,000 | $2.05 | $102,500.00 | 38% 131.31K to 181.31K | (63%) |
| 23-Mar-21 5:24 PM View: | Altomari Alfred Chief Executive Officer Director | Agile Therapeutics, Inc. (AGRX) | 23-Mar-21 | Market Purchase | 12,500 | $2.00 | $25,030.00 | 3% 456.21K to 468.71K | (63%) |
| 28-Jan-21 6:34 PM View: | Conway Robert G SVP Chief Supply Chain Officer | Agile Therapeutics, Inc. (AGRX) | 27-Jan-21 | Grant | 35,461 | -- | -- | 155% 22.9K to 58.36K | |
| 23-Nov-20 5:00 PM View: | Conway Robert G SVP Chief Supply Chain Officer | Agile Therapeutics, Inc. (AGRX) | 19-Nov-20 | Option Exercise | 4,149 | $1.76 | $7,302.24 | 22% 18.75K to 22.9K |
